Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients

This study aims for evaluating the effectiveness, safety and feasibility of additional acupuncture therapy for lung cancer patients who are under chemotherapy in an inpatient setting. The acupuncture therapy will be administered during a resting period between cycles of chemotherapy.

Inclusion Criteria:

• At least 18 years of age
• Karnofsky Performance Status (KPS) 60% or more
• Undergoing antineoplastic chemotherapy for lung cancer
• Able to provide informed consent

Exclusion Criteria:

• Brain metastasis, stroke or major psychiatric diseases
• Active infection
• Severe heart disease
• Serious systemic diseases such as uncontrolled hypertension and diabetes mellitus
• Acupuncture therapy within the previous three months
• Communication disorder
• Unwillingness to participate in the trial
• Severe immunocompromised state (absolute neutrophils count < 1000/cubic mm)